These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7748170

  • 21. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA.
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [Abstract] [Full Text] [Related]

  • 22. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
    Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simöes M.
    Oncogene; 2001 Mar 22; 20(12):1525-8. PubMed ID: 11313896
    [Abstract] [Full Text] [Related]

  • 23. Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online.
    Becker KF, Reich U, Schott C, Becker I, Berx G, van Roy F, Höfler H.
    Hum Mutat; 1999 Mar 22; 13(2):171. PubMed ID: 10094558
    [Abstract] [Full Text] [Related]

  • 24. The interactions of APC, E-cadherin and beta-catenin in tumour development and progression.
    Ilyas M, Tomlinson IP.
    J Pathol; 1997 Jun 22; 182(2):128-37. PubMed ID: 9274521
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. E-cadherin and catenins: molecules with versatile roles in normal and neoplastic epithelial cell biology.
    El-Bahrawy MA, Pignatelli M.
    Microsc Res Tech; 1998 Nov 01; 43(3):224-32. PubMed ID: 9840800
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas.
    Candidus S, Bischoff P, Becker KF, Höfler H.
    Cancer Res; 1996 Jan 01; 56(1):49-52. PubMed ID: 8548773
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM, Dobo E, Norton JA, Van Dam J, Jeffrey RB, Huntsman DG, Kingham K, Chun N, Ford JM, Longacre TA.
    Am J Surg Pathol; 2008 Jun 01; 32(6):799-809. PubMed ID: 18391748
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.
    Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB.
    Cancer Res; 1993 Aug 01; 53(15):3585-90. PubMed ID: 8339265
    [Abstract] [Full Text] [Related]

  • 36. [Diffuse stomach carcinoma: from H&E diagnosis and molecular pathology to specific therapy].
    Höfler H.
    Verh Dtsch Ges Pathol; 1999 Aug 01; 83():148-54. PubMed ID: 10714205
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
    Zhou YN, Xu CP, Han B, Ji R.
    Ai Zheng; 2005 Oct 01; 24(10):1220-4. PubMed ID: 16219136
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.